Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 3;61(4):664.
doi: 10.3390/medicina61040664.

New Frontiers in Nutritional and Therapeutic Interventions for Obesity Phenotypes

Affiliations
Review

New Frontiers in Nutritional and Therapeutic Interventions for Obesity Phenotypes

Angelo Maria Patti et al. Medicina (Kaunas). .

Abstract

The heterogeneity among patients with obesity is particularly evident in the weight loss response to interventions such as diets, drugs, devices and surgery. Obesity can be "catalogued" into four phenotypes: hungry brain (abnormal satiety for alteration of gut-brain axis), emotional hunger (hedonic eating), hungry gut (abnormal duration of satiety for faster gastric emptying) and slow burning (slowing of the metabolic rate). Phenotypes are grafted onto this complexity, the recognition of which allows for personalized medicine and increasingly targeted therapies. Although there are no standardized treatment protocols, we present management options consisting of lifestyle modifications and pharmacologic therapies. Nutritional advice and encouragement of adequate physical activity lead to increased self-efficacy and promote a sense of well-being when coupled with psychological approaches involving mindful eating. In summary, obesity has a complex pathophysiology best addressed through a therapeutic process suited to the phenotype encountered and in synergy with multifactorial interventions.

Keywords: drugs; gut–brain axis; obesity phenotypes; personalized medicine; therapies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart of the research strategy.
Figure 2
Figure 2
Obesity phenotypes and treatments.
Figure 3
Figure 3
Hypothetical management approach for the 4 obesity phenotypes.

Similar articles

References

    1. Rubino F., Cummings D.E., Eckel R.H., Cohen R.V., Wilding J.P.H., Brown W.A., Stanford F.C., Batterham R.L., Farooqi I.S., Farpour-Lambert N.J., et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221–262. doi: 10.1016/s2213-8587(24)00316-4. Erratum in Lancet Diabetes Endocrinol. 2025, 13, e6. 10.1016/S2213-8587(25)00006-3. - DOI - DOI - PMC - PubMed
    1. Koskinas K.C., Van Craenenbroeck E.M., Antoniades C., Blüher M., Gorter T.M., Hanssen H., Marx N., McDonagh T.A., Mingrone G., Rosengren A., et al. Obesity and cardiovascular disease: An ESC clinical consensus statement. Eur. J. Prev. Cardiol. 2025;32:184–220. doi: 10.1093/eurjpc/zwae279. - DOI - PubMed
    1. Cross L. Management of obesity. Am. J. Health Syst. Pharm. 2025;82:48–59. doi: 10.1093/ajhp/zxae273. - DOI - PubMed
    1. Lavie C.J., De Schutter A., Patel D.A., Romero-Corral A., Artham S.M., Milani R.V. Body composition and survival in stable coronary heart disease: Impact of lean mass index and body fat in the “obesity paradox”. J. Am. Coll. Cardiol. 2012;60:1374–1380. doi: 10.1016/j.jacc.2012.05.037. - DOI - PubMed
    1. Marx N., Federici M., Schütt K., Müller-Wieland D., Ajjan R.A., Antunes M.J., Christodorescu R.M., Crawford C., Di Angelantonio E., Eliasson B., et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur. Heart J. 2024;45:518. doi: 10.1093/eurheartj/ehad857. - DOI - PubMed

LinkOut - more resources